IL103156A - Process for the preparation of anti-ulcer pyridylmethyl sulfinyl benzimidazole derivatives - Google Patents

Process for the preparation of anti-ulcer pyridylmethyl sulfinyl benzimidazole derivatives

Info

Publication number
IL103156A
IL103156A IL10315692A IL10315692A IL103156A IL 103156 A IL103156 A IL 103156A IL 10315692 A IL10315692 A IL 10315692A IL 10315692 A IL10315692 A IL 10315692A IL 103156 A IL103156 A IL 103156A
Authority
IL
Israel
Prior art keywords
ulcer
preparation
benzimidazole derivatives
bridge
sulfinyl benzimidazole
Prior art date
Application number
IL10315692A
Other versions
IL103156A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL103156A0 publication Critical patent/IL103156A0/en
Publication of IL103156A publication Critical patent/IL103156A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Anti-ulcer agents having a methylsulfinyl bridge between a substituted pyridine moiety and a substituted benzimidazole moiety are prepared by oxidizing the corresponding compounds, having a methylthio bridge, with magnesium monoperoxyphthalate in a suitable solvent. The reaction may be run in an aromatic hydrocarbon solvent, wherein the product may crystallize out of the reaction solution and may be directly isolated by filtration.
IL10315692A 1991-09-20 1992-09-14 Process for the preparation of anti-ulcer pyridylmethyl sulfinyl benzimidazole derivatives IL103156A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76456491A 1991-09-20 1991-09-20
US77787391A 1991-10-15 1991-10-15

Publications (2)

Publication Number Publication Date
IL103156A0 IL103156A0 (en) 1993-02-21
IL103156A true IL103156A (en) 1997-02-18

Family

ID=27117485

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10315692A IL103156A (en) 1991-09-20 1992-09-14 Process for the preparation of anti-ulcer pyridylmethyl sulfinyl benzimidazole derivatives

Country Status (18)

Country Link
US (1) US5391752A (en)
EP (1) EP0533264B1 (en)
JP (1) JPH0720956B2 (en)
KR (1) KR100242622B1 (en)
CN (1) CN1048729C (en)
AT (1) ATE186535T1 (en)
AU (1) AU649355B2 (en)
CA (1) CA2078517C (en)
DE (1) DE69230278T2 (en)
DK (1) DK0533264T3 (en)
ES (1) ES2143468T3 (en)
GR (1) GR3032619T3 (en)
IL (1) IL103156A (en)
MX (1) MX9205333A (en)
NZ (1) NZ244301A (en)
PT (1) PT533264E (en)
WO (1) WO1993006097A1 (en)
YU (1) YU48291B (en)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9002043D0 (en) * 1990-06-07 1990-06-07 Astra Ab IMPROVED METHOD FOR SYNTHESIS
US5504082A (en) * 1992-06-01 1996-04-02 Yoshitomi Pharmaceutical Industries, Ltd. Pyridine compound and pharmaceutical compostions
KR950701921A (en) * 1992-06-01 1995-05-17 고야 다다시 Pyridine Compound and its Pharmaceutical Use (PYRIDINE COMPOUND AND MEDICINAL USE THEREOF)
SE521100C2 (en) * 1995-12-15 2003-09-30 Astra Ab Process for the preparation of a benzimidazole compound
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6489346B1 (en) * 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
CN1053444C (en) * 1996-03-20 2000-06-14 常州市第四制药厂 Process for refining omeprazole
SE508669C2 (en) * 1996-04-26 1998-10-26 Astra Ab New procedure
SK283805B6 (en) * 1996-09-09 2004-02-03 Slovakofarma, A. S. Method of omeprazole preparation
SE9704183D0 (en) 1997-11-14 1997-11-14 Astra Ab New process
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6191148B1 (en) 1998-08-11 2001-02-20 Merck & Co., Inc. Omerazole process and compositions thereof
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
DE19951960C2 (en) 1999-10-28 2002-06-27 Gruenenthal Gmbh Process for the preparation of benzimidazole derivatives suitable as ulcer therapeutics
PL368563A1 (en) * 2001-02-02 2005-04-04 Teva Pharmaceutical Industries Ltd. Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1h-benzimidazoles
KR100783020B1 (en) * 2001-03-23 2007-12-07 동아제약주식회사 2-Methylchloride Pyridine Derivative and Preparation Method of Benzimidazole Derivative Using the Same
EP1409478B1 (en) * 2001-07-16 2006-03-29 Janssen Pharmaceutica N.V. Improved process for preparing benzimidazole-type compounds
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
WO2004012659A2 (en) * 2002-08-01 2004-02-12 Nitromed, Inc. Nitrosated proton pump inhibitors, compositions and methods of use
SE0203092D0 (en) * 2002-10-18 2002-10-18 Astrazeneca Ab Method for the synthesis of a benzimidazole compound
US7507829B2 (en) 2002-12-19 2009-03-24 Teva Pharmaceuticals Industries, Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
ES2324665T3 (en) * 2003-01-15 2009-08-12 Cipla Limited PHARMACEUTICAL PROCESS AND COMPOUNDS PREPARED THROUGH THE SAME.
US20040248942A1 (en) * 2003-02-20 2004-12-09 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
WO2004080961A2 (en) * 2003-03-12 2004-09-23 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous solids of pantoprazole and processes for their preparation
US7683177B2 (en) 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2005007117A2 (en) * 2003-07-18 2005-01-27 Santarus, Inc. Pharmaceutical formulation and method for treating acid-caused gastrointestinal disorders
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
CA2563808A1 (en) * 2004-04-28 2005-11-10 Altana Pharma Ag Dialkoxy-imidazopyridines derivatives
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CN103121992A (en) * 2004-06-24 2013-05-29 阿斯利康(瑞典)有限公司 New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
GB0525710D0 (en) * 2005-12-17 2006-01-25 Pliva Hrvatska D O O An improved process for preparing of substituted 2-benzimidazolesulfoxide compounds
WO2008017020A2 (en) * 2006-08-03 2008-02-07 Dr. Reddy's Laboratories Limited Process for preparing proton pump inhibitors
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EA200900985A1 (en) 2007-01-31 2009-12-30 Крка, Товарна Здравил, Д. Д., Ново Место METHOD OF OBTAINING OPTICAL PURE OMEPRAZOL
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN104203938A (en) 2012-01-21 2014-12-10 朱比兰特生命科学有限公司 Process for the preparation of 2-pyridylmethylsulfinylbenzimidazoles, their analogs and optically active enantiomers

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (en) * 1978-04-14 1979-10-15 Haessle Ab Gastric acid secretion
US4483781A (en) * 1983-09-02 1984-11-20 The Procter & Gamble Company Magnesium salts of peroxycarboxylic acids
JPS6150978A (en) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd Pyridine derivative and preparation thereof
JPS61178919A (en) * 1985-02-04 1986-08-11 Banyu Pharmaceut Co Ltd Benzimidazole derivative and drug containing same
JPS62201884A (en) * 1986-02-28 1987-09-05 Tokyo Tanabe Co Ltd Benzimidazole derivative
JPH0643426B2 (en) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 Imidazo [4,5-b] pyridine derivative, method for producing the same, and antiulcer agent containing the same
FI864046A7 (en) * 1986-10-07 1988-04-08 Farmos Oy Method for preparing a therapeutically active compound.
FI90544C (en) * 1986-11-13 1994-02-25 Eisai Co Ltd Process for Preparation as Drug Useful 2-Pyridin-2-yl-methylthio- and sulfinyl-1H-benzimidazole derivatives
DE3722810A1 (en) * 1987-07-10 1989-01-19 Hoechst Ag SUBSTITUTED BENZIMIDAZOLES, METHOD FOR THE PRODUCTION THEREOF, THE PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND THE USE THEREOF
DK171989B1 (en) * 1987-08-04 1997-09-08 Takeda Chemical Industries Ltd Process for the preparation of 2- (2-pyridylmethylsulfinyl) benzimidazoles
WO1989005299A1 (en) * 1987-12-11 1989-06-15 Byk Gulden Lomberg Chemische Fabrik Gmbh Novel benzimidazole derivatives
SE8804628D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW COMPOUNDS
SE8804629D0 (en) * 1988-12-22 1988-12-22 Ab Haessle NEW THERAPEUTICALLY ACTIVE COMPOUNDS
FR2660313B1 (en) * 1990-04-02 1992-07-03 Fournier Ind & Sante NEW SULFONYL-PHENYL-BETHA-D-THIOXYLOSIDES, THEIR PREPARATION PROCESS AND THEIR USE IN THERAPEUTICS.

Also Published As

Publication number Publication date
DE69230278T2 (en) 2001-04-05
AU2520792A (en) 1993-03-25
EP0533264B1 (en) 1999-11-10
CN1048729C (en) 2000-01-26
DE69230278D1 (en) 1999-12-16
NZ244301A (en) 1994-08-26
JPH0720956B2 (en) 1995-03-08
PT533264E (en) 2000-05-31
IL103156A0 (en) 1993-02-21
MX9205333A (en) 1993-07-01
ES2143468T3 (en) 2000-05-16
KR100242622B1 (en) 2000-03-02
DK0533264T3 (en) 2000-05-15
ATE186535T1 (en) 1999-11-15
US5391752A (en) 1995-02-21
WO1993006097A1 (en) 1993-04-01
JPH05213936A (en) 1993-08-24
AU649355B2 (en) 1994-05-19
CA2078517A1 (en) 1993-03-21
EP0533264A1 (en) 1993-03-24
GR3032619T3 (en) 2000-05-31
YU48291B (en) 1998-05-15
KR930006021A (en) 1993-04-20
YU89492A (en) 1995-10-03
CN1071169A (en) 1993-04-21
CA2078517C (en) 2003-11-04

Similar Documents

Publication Publication Date Title
IL103156A (en) Process for the preparation of anti-ulcer pyridylmethyl sulfinyl benzimidazole derivatives
ATE79377T1 (en) NEW PICOLINE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, THEIR APPLICATION AND MEDICINES CONTAINING THEM.
DE59005587D1 (en) Salicylaldehyde and salicylic acid derivatives and their sulfur analogs, processes for their preparation and their use as herbicides and bioregulators.
FI861262A7 (en) 5- 5-(6-IMIDAZO(1,2-A)PYRIDYL)PYRIDINE DERIVATIVE.
IE851205L (en) Beta-carbolines
NO880556L (en) PYRIDINE-2,4- AND 2,5-DICARBOXYLIC ACID DERIVATIVES, AND PROCEDURES FOR THE PREPARATION OF THE COMPOUNDS.
AU588357B2 (en) A process for the production of oxides of aromatic tertiary amines and products obtained in this way
DE3161861D1 (en) Thioformamide derivatives, their preparation and pharmaceutical preparations containing them
DE3887357D1 (en) Substituted 2,6-substituted pyridine compounds.
ATE23530T1 (en) HETEROCYCLIC NITRILES, THEIR PRODUCTION AND USE IN THE PREPARATION OF MEDICATIONS.
AU589522B2 (en) Substituted 2,6-substituted pyridine compounds
IL112157A (en) Method for the preparation of pyridine-2,3-dicarboxylic acids
NO167457C (en) PROCEDURE FOR PREPARING 4-ACETYL-1-METHYL-7- (4-PYRIDYL) -5,6,7,8-TETRAHYDRO-3 (2H) -ISOKINOLINON
DE68929429D1 (en) Process for the preparation of pyridine-2,3-dicarboxylic acid compounds
FR2587705B1 (en) PROCESS FOR THE PREPARATION OF OXIDIZED AROMATIC NITROGEN HETEROCYCLIC DERIVATIVES SUCH AS PYRIDINE N-OXIDE
PT79056A (en) Process for preparing pyridyl n-oxides
AU2673588A (en) 1,4-dihydropyridine derivatives as neuroprotective compounds
ATE100806T1 (en) SUBSTITUTED 2,6-SUBSTITUTED PYRIDINE COMPOUNDS.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees